P53 regulates Period2 expression and the circadian clock

Nature Communications

Volumn 4, Issue , 2013, Pages

  Miki, Takao ^a,b   Matsumoto, Tomoko ^a   Zhao, Zhaoyang ^a   Lee, Cheng Chi ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUTLIN 3; PER2 PROTEIN; PROTEIN BMAL1; PROTEIN P53; TRANSCRIPTION FACTOR CLOCK;

CIRCADIAN RHYTHM; GENE EXPRESSION; GENOTOXICITY; RODENT;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELLULAR STRESS RESPONSE; CIRCADIAN RHYTHM; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; E BOX ELEMENT; GENE REPRESSION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION INITIATION;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; BEHAVIOR, ANIMAL; BINDING SITES; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; CLOCK PROTEINS; GENE EXPRESSION REGULATION; IMIDAZOLES; LIGHT; MICE; MICE, KNOCKOUT; PERIOD CIRCADIAN PROTEINS; PIPERAZINES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; TUMOR SUPPRESSOR PROTEIN P53; VISUAL PERCEPTION;

EID: 84884697860     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3444     Document Type: Article

References (60)

1. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992)
2. Li, F. & Fraumeni, Jr J. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J. Natl. Cancer. I 43, 1365-1373 (1969)
3. Hollstein, M., Sidransky, D. & Vogelstein, B. p53 mutations in human cancers. Science 253, 49-53 (1991) (Pubitemid 21917115)
4. Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413-431 (2009)
5. Takahashi, J. S. Molecular neurobiology and genetics of circadian rhythms in mammals. Annu. rev. Neurosci. 18, 531-553 (1995)
6. Miki, T. et al. PML regulates PER2 nuclear localization and circadian function. The EMBO J. 31, 1427-1439 (2012)
7. Hofmann, T. G. & Will, H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10, 1290-1299 (2003) (Pubitemid 37536734)
8. Reineke, E. L. & Kao, H.-Y. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int. J. Biol. Sci. 5, 366-376 (2009)
9. Nakahata, Y. et al. The NAD?-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329-340 (2008) (Pubitemid 352010336)
10. Lee, Y. et al. Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. J. Cell Sci. 123, 3547-3557 (2010)
11. Duong, H. a., Robles, M. S., Knutti, D. & Weitz, C. J. A molecular mechanism for circadian clock negative feedback. Science 332, 1436-1439 (2011)
12. Brown, S. a. et al. PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator. Science 308, 693-696 (2005) (Pubitemid 40594390)
13. Cheng, H.-L. et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl Acad. Sci. 100, 10794-10799 (2003) (Pubitemid 37140107)
14. Pearson, M. et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210 (2000) (Pubitemid 30469006)
15. Langley, E. et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383-2396 (2002) (Pubitemid 34546711)
16. Vousden, K. H. & Ryan, K. M. P53 and Metabolism. Nat. Rev. Cancer 9, 691-700 (2009)
17. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004) (Pubitemid 38174664)
18. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997) (Pubitemid 27220766)
19. Joseph, T. W., Zaika, A. & Moll, U. M. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. FASEB J. 17, 1622-1630 (2003) (Pubitemid 37100063)
20. Wang, B., Xiao, Z., Ko, H. L. & Ren, E. C. The p53 response element and transcriptional repression. Cell Cycle 9, 870-879 (2010)
21. Akashi, M., Ichise, T., Mamine, T. & Takumi, T. Molecular mechanism of cellautonomous circadian gene expression of Period2, a crucial regulator of the mammalian circadian clock. Mol. Biol. Cell 17, 555-565 (2006) (Pubitemid 43191092)
22. Yoo, S.-H. et al. A noncanonical E-box enhancer drives mouse Period2 circadian oscillations in vivo. Proc. Natl Acad. Sci. 102, 2608-2613 (2005) (Pubitemid 40279424)
23. Gréchez-Cassiau, A., Rayet, B., Guillaumond, F., Teboul, M. & Delaunay, F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283, 4535-4542 (2008)
24. Fu, L., Pelicano, H., Liu, J., Huang, P. & Lee, C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111, 41-50 (2002)
25. Bjarnason, G. A., Jordan, R. C. & Sothern, R. B. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am. J. Pathol. 154, 613-622 (1999) (Pubitemid 29094110)
26. Moore, R. Y. Circadian rhythms: basic neurobiology and clinical applications. Annu. rev. Med. 48, 253-266 (1997) (Pubitemid 27101829)
27. Secchiero, P., Bosco, R., Celeghini, C. & Zauli, G. Recent advances in the therapeutic perspectives of Nutlin-3. Curr. Pharm. Design 17, 569-577 (2011)
28. Spoelstra, K., Albrecht, U., Van der Horst, G. T. J., Brauer, V. & Daan, S. Phase responses to light pulses in mice lacking functional per or cry genes. J. Biol. Rhythms 19, 518-529 (2004) (Pubitemid 39507177)
29. Sancar, A. et al. Circadian clock control of the cellular response to DNA damage. FEBS Lett. 584, 2618-2625 (2010)
30. Hunt, T. & Sassone-Corsi, P. Riding tandem: circadian clocks and the cell cycle. Cell 129, 461-464 (2007) (Pubitemid 46660976)
31. Miyazaki, K., Wakabayashi, M., Chikahisa, S., Sei, H. & Ishida, N. PER2 controls circadian periods through nuclear localization in the suprachiasmatic nucleus. Genes Cells. 12, 1225-1234 (2007) (Pubitemid 350042420)
32. Vanselow, K. et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS) rfsti Genes. Dev.20, 2660-2672 2006.Genes. dev. 20, 2660-2672 (2006) (Pubitemid 44498377)
33. Godar, S. et al. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 134, 62-73 (2008) (Pubitemid 351905743)
34. Meletis, K. et al. P53 suppresses the self-renewal of adult neural stem cells. Development 133, 363-369 (2006) (Pubitemid 43210724)
35. Zheng, B. et al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105, 683-694 (2001) (Pubitemid 32524120)
36. Yan, L. & Silver, R. Differential induction and localization of mPer1 and mPer2 during advancing and delaying phase shifts. Eur. J. Neurosci. 16, 1531-1540 (2002) (Pubitemid 35334990)
37. Nagano, M., Adachi, A., Masumoto, K., Meyer-Bernstein, E. & Shigeyoshi, Y. rPer1 and rPer2 induction during phases of the circadian cycle critical for light resetting of the circadian clock. Brain Res. 1289, 37-48 (2009)
38. Albrecht, U., Zheng, B., Larkin, D., Sun, Z. S. & Lee, C. C. mPer1 and mPer2 are essential for normal resetting of the circadian clock. J. Biol. Rhythms 16, 100-104 (2001) (Pubitemid 32391905)
39. Gamsby, J., Loros, J. & Dunlap, J. C. A phylogenetically conserved DNA damage response resets the circadian clock. J. Biol. Rhythms 24, 193-202 (2009)
40. Latonen, L., Taya, Y. & Laiho, M. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20, 6784-6793 (2001) (Pubitemid 33020607)
41. Oklejewicz, M. et al. Phase resetting of the mammalian circadian clock by DNA damage. Curr. Biol. 18, 286-291 (2008)
42. Badura, L. et al. An inhibitor of casein kinase i induces phase delays in circadian rhythms under free-running and entrained conditions. Pharmacology 322, 730-738 (2007) (Pubitemid 47105782)
43. Eide, E. J. et al. Control of mammalian circadian rhythm by CKIe-regulated proteasome-mediated PER2 degradation. Mol. Cell. Biol 25, 2795-2807 (2005) (Pubitemid 40381641)
44. Tyner, S. D. et al. P53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (2002) (Pubitemid 34062443)
45. Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306-319 (2004) (Pubitemid 38199255)
46. Pehar, M. et al. Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death. Aging Cell 9, 174-190 (2010)
47. Lee, C. C. Tumor suppression by the mammalian Period genes. Cancer Causes Control 17, 525-530 (2006)
48. Pilorz, V. & Steinlechner, S. Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing? Reproduction 135, 559-568 (2008) (Pubitemid 351578162)
49. De Stanchina, E. et al. PML is a direct p53 target that modulates p53 effector functions. Mol. Cell 13, 523-535 (2004) (Pubitemid 38299380)
50. Kaasik, K. & Lee, C. C. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 430, 467-471 (2004) (Pubitemid 38987910)
51. Miki, T. et al. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J. Biol. Chem. 282, 12341-12352 (2007) (Pubitemid 47100672)
52. Yoshitane, H. et al. Roles of CLOCK phosphorylation in suppression of E-boxdependent transcription. Mol. Cell Biol. 29, 3675-3686 (2009)
53. Kiyama, R. & Camerini-Otero, R. D. A triplex DNA-binding protein from human cells: purification and characterization. Proc. Natl Acad. Sci. 88, 10450-10454 (1991)
54. Ye, R., Selby, C. P., Ozturk, N., Annayev, Y. & Sancar, A. Biochemical analysis of the canonical model for the mammalian circadian clock. J. Biol. Chem. 286, 25891-25902 (2011)
55. Oishi, K., Shirai, H. & Ishida, N. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor a ( PPAR a ) in mice. Biochem. J. 386, 575-581 (2005) (Pubitemid 40445883)
56. Bieda, M., Xu, X., Singer, M. A., Green, R. & Farnham, P. J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16, 595-605 (2006)
57. Mukhopadhyay, A., Deplancke, B., Walhout, A. J. M. & Tissenbaum, H. a. Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat. Protoc. 3, 698-709 (2008) (Pubitemid 351516764)
58. Hasegawa, H. et al. Laminar patterning in the developing neocortex by temporally coordinated fibroblast growth factor signaling. J. Neurosci 24, 8711-8719 (2004) (Pubitemid 39362966)
59. Albrecht, U., Sun, Z. S., Eichele, G. & Lee, C. C. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91, 1055-1064 (1997) (Pubitemid 28027837)
60. Zheng, B. et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400, 169-173 (1999). (Pubitemid 29327546)